<DOC>
	<DOCNO>NCT01800045</DOCNO>
	<brief_summary>Double blind , randomize , parallel group study Pitolisant versus placebo , narcoleptic patient experience EDS , cataplexy ( minimum 3 complete partial cataplexy attack per week ) . The patient treat 7 week Pitolisant placebo .</brief_summary>
	<brief_title>Pitolisant Assess Weekly Frequency Cataplexy Attacks EDS Narcoleptic Patients ( HARMONY CTP )</brief_title>
	<detailed_description>The treatment period ( 7 week double blind ) aim demonstrate efficacy Pitolisant number cataplexy attack Excessive Daytime Sleepiness verify whether result Pitolisant superior placebo . The safety also assess .</detailed_description>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<criteria>Main Narcoleptic cataplexy : least 3 weekly cataplexy attack ESS &gt; = 12 ICF sign date Main Other condition could generate EDS Psychological neurological disorder Acute chronic severe disease Treatment prohibit medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Narcolepsy</keyword>
	<keyword>Cataplexy</keyword>
	<keyword>Sleep disorder</keyword>
	<keyword>Excessive daytime sleepiness</keyword>
</DOC>